PHENPROCOUMON: 1,387 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
1,387
Total FAERS Reports
140 (10.1%)
Deaths Reported
1,068
Hospitalizations
1,387
As Primary/Secondary Suspect
214
Life-Threatening
22
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
FDA Application: 011228 ·
First Report: 19990501 · Latest Report: 20250105
What Are the Most Common PHENPROCOUMON Side Effects?
#1 Most Reported
Anaemia
242 reports (17.4%)
#2 Most Reported
General physical health deterioration
172 reports (12.4%)
#3 Most Reported
Haematochezia
162 reports (11.7%)
All PHENPROCOUMON Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 242 | 17.5% | 1 | 230 |
| General physical health deterioration | 172 | 12.4% | 4 | 171 |
| Haematochezia | 162 | 11.7% | 5 | 162 |
| Dyspnoea | 140 | 10.1% | 6 | 130 |
| Gastrointestinal haemorrhage | 122 | 8.8% | 29 | 68 |
| Overdose | 109 | 7.9% | 13 | 96 |
| Dizziness | 108 | 7.8% | 11 | 87 |
| Haematoma | 108 | 7.8% | 24 | 76 |
| Product prescribing error | 104 | 7.5% | 4 | 101 |
| Fall | 92 | 6.6% | 5 | 87 |
| International normalised ratio increased | 81 | 5.8% | 4 | 57 |
| Product monitoring error | 76 | 5.5% | 0 | 76 |
| Haemorrhage | 67 | 4.8% | 5 | 47 |
| Atrial fibrillation | 66 | 4.8% | 2 | 63 |
| Nausea | 63 | 4.5% | 2 | 61 |
| Oedema peripheral | 63 | 4.5% | 2 | 60 |
| Haemoglobin decreased | 61 | 4.4% | 2 | 57 |
| Drug interaction | 59 | 4.3% | 15 | 29 |
| Renal failure | 58 | 4.2% | 35 | 24 |
| Acute kidney injury | 56 | 4.0% | 6 | 40 |
Who Reports PHENPROCOUMON Side Effects? Age & Gender Data
Gender: 45.8% female, 54.2% male. Average age: 71.3 years. Most reports from: DE. View detailed demographics →
Is PHENPROCOUMON Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2003 | 15 | 7 | 8 |
| 2005 | 10 | 1 | 10 |
| 2007 | 5 | 1 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 8 | 0 | 7 |
| 2010 | 8 | 0 | 6 |
| 2011 | 9 | 1 | 8 |
| 2012 | 6 | 1 | 4 |
| 2013 | 40 | 3 | 31 |
| 2014 | 49 | 3 | 43 |
| 2015 | 104 | 16 | 77 |
| 2016 | 53 | 7 | 45 |
| 2017 | 137 | 24 | 106 |
| 2018 | 61 | 2 | 41 |
| 2019 | 42 | 9 | 29 |
| 2020 | 69 | 1 | 58 |
| 2021 | 65 | 11 | 43 |
| 2022 | 15 | 1 | 12 |
| 2023 | 5 | 0 | 3 |
| 2024 | 7 | 2 | 2 |
| 2025 | 1 | 0 | 0 |
What Is PHENPROCOUMON Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 707 |
| Atrial fibrillation | 182 |
| Anticoagulant therapy | 90 |
| Thrombosis prophylaxis | 28 |
| Cardiac disorder | 24 |
| Pulmonary embolism | 16 |
| Deep vein thrombosis | 11 |
| Heart valve replacement | 11 |
| Mitral valve replacement | 11 |
| Factor v deficiency | 10 |
PHENPROCOUMON vs Alternatives: Which Is Safer?
PHENPROCOUMON vs PHENTERMINE
PHENPROCOUMON vs PHENTERMINE\TOPIRAMATE
PHENPROCOUMON vs PHENTOLAMINE
PHENPROCOUMON vs PHENYLEPHRINE
PHENPROCOUMON vs PHENYLEPHRINE\PHENYLEPHRINE
PHENPROCOUMON vs PHENYLPROPANOLAMINE
PHENPROCOUMON vs PHENYTOIN
PHENPROCOUMON vs PHLEUM PRATENSE POLLEN
PHENPROCOUMON vs PHLOROGLUCINOL
PHENPROCOUMON vs PHLOROGLUCINOL\1,3,5-TRIMETHOXYBENZENE
Official FDA Label for PHENPROCOUMON
Official prescribing information from the FDA-approved drug label.